The main headlines of Fox Business Flash are here. Check out what is clicking on FoxBusiness.com.
AstraZeneca Plc sold its 7.7% stake in Moderna Inc for more than $ 1 billion after the US biotech firm’s stock soared due to the discovery of the coronavirus vaccine, The Times reported.
| Ticker | Safety | Last | Change | Change % |
|---|---|---|---|---|
| AZN | ASTRAZENECA PLC | 48.38 | -0.53 | -1.08% |
| MRNA | MODERNA, INC. | 154.81 | +6.43 | + 4.33% |
The report added that it was unclear when Britain-based AstraZeneca sold its stake in Moderna.
AMONG VACCINE DELAYS, ASTRAZENECA MAY HAVE VIOLATED THE EU CONTRACT ON COVID-19 SHOTS
AstraZeneca and Moderna did not immediately respond to requests for comment.
AstraZeneca Plc sold its 7.7% stake in Moderna Inc for more than $ 1 billion after the US biotech firm’s stock soared because of its discovery of the coronavirus vaccine. (Melissa Melvin / AP Images for Tyson Foods File)
AstraZeneca is partnering with Moderna on other disease treatments and may sell its COVID-19 AstraZeneca / Oxford University vaccine on a commercial basis in the future if the virus becomes endemic, the report added.
Moderna, whose vaccine is released for emergency use against COVID-19 in the United States, said last week that it expected sales of $ 18.4 billion of its coronavirus vaccine this year.